Dr. Dong Shen, MD, PhD

CEO at RNAimmune, Inc.

Speaker

Dr. Dong Shen is the Founder and CEO of RNAimmune, Inc., a clinical-stage biotechnology company specializing in mRNA vaccines and therapeutics. He earned his MD from Shanghai Jiao Tong University School of Medicine and his PhD from Johns Hopkins University School of Medicine under Dr. Bert Vogelstein. A leader in AI-driven mRNA technology, Dr. Shen has guided RNAimmune to global recognition with 35 patents, advanced lipid nanoparticle innovations, and a diverse pipeline targeting RSV, COVID-19, cancer, and more. In 2023, RNAimmune’s RSV vaccine became the first FDA IND-approved in Asia. With over 23,000 citations, Dr. Shen continues to drive healthcare innovation worldwide.